Prognostic value of thymidine phosphorylase expression for pancreatic cancer

Hepato-Gastroenterology

Volumn 56, Issue 93, 2009, Pages 1178-1182

  Hong, Sung Pil ^a   Shin, Sung Kwan ^a   Bang, Seungmin ^a   Park, Seung Woo ^a   Chung, Jae Bock ^a   Lee, Woo Jung ^a   Song, Si Young ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Immunohistochemistry; Neovascularization; Pancreatic neoplasms; Prognosis; Thymidine phosphorylase

Indexed keywords

THYMIDINE PHOSPHORYLASE;

ADULT; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; ENZYMOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL RATE;

CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; THYMIDINE PHOSPHORYLASE;

EID: 70350482248     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30 (Pubitemid 40310185)
2. Kalser MH, Barkin J, MacIntyre JM: Pancreatic cancer. Assessment of prognosis by clinical presentation. Cancer 1985; 56:397-402 (Pubitemid 15031666)
3. Yeo CJ, Cameron JL, Sohn TA, et al.: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997; 226:248-257; discussion 257
4. Iltzsch MH, el Kouni MH, Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985; 24:6799-6807 (Pubitemid 16170208)
5. Haraguchi M, Miyadera K, Uemura K, et al.: Angiogenic activity of enzymes. Nature 1994; 368:198
6. Moghaddam A, Zhang HT, Fan TP, et al.: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci U S A 1995; 92:998-1002
7. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T: The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 1995; 92:1-7
8. Takao S, Takebayashi Y, Che X, et al.: Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin Cancer Res 1998; 4:1619-1624 (Pubitemid 28304722)
9. Imazano Y, Takebayashi Y, Nishiyama K, et al.: Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 1997; 15:2570-2578 (Pubitemid 27289887)
10. Salonga D, Danenberg KD, Johnson M, et al.: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. Clin Cancer Res 2000; 6:1322-1327 (Pubitemid 30226214)
11. Fujioka S, Yoshida K, Yanagisawa S, Kawakami M, Aoki T, Yamazaki Y: Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 2001; 92:1788-1797 (Pubitemid 32952497)
12. Takebayashi Y, Yamada K, Miyadera K, et al.: The activity and expression of thymidine phosphorylase in human solid tumours. Eur J Cancer 1996; 32A:1227-1232 (Pubitemid 26231808)
13. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61 (Pubitemid 19115892)
14. Rak J, Filmus J, Kerbel RS: Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A:2438-2450
15. Frank RE, Saclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB: Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995; 222:695-699 (Pubitemid 26001232)
16. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ: The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 1997; 57:570-572 (Pubitemid 27085632)
17. Fujimoto K, Hosotani R, Wada M, et al.: Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship to angiogenesis. Eur J Cancer 1998; 34:1439-1447 (Pubitemid 28370938)
18. Ikeda N, Adachi M, Taki T, et al.: Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999; 79:1553-1563 (Pubitemid 29116820)
19. Matsushita S, Nitanda T, Furukawa T, et al.: The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 1999; 59:1911-1916 (Pubitemid 29186165)
20. Jinfeng M, Kimura W, Sakurai F, Moriya T, Mizutani M, Hirai I: Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas. Hepatogastroenterology 2007; 54:1635-1640 (Pubitemid 350068442)
21. Tsukamoto Y, Kato Y, Ura M, et al.: A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. Pharm Res 2001; 18:1190-1202 (Pubitemid 32900406)